CORCEPT THERAPEUTICS I
54.30
07-نوفمبر-24 15:59:58
15 متأخرة بدقائق
الأسهم
+0.07
+0.13%
نطاق اليوم
53.65 - 55.24
ISIN
N/A
المصدر
NASDAQ
-
Corcept Therapeutics Initiates DAZALS – A Phase 2 Trial in Amyotrophic Lateral Sclerosis (ALS)
11 أكتوبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
03 أغسطس 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
29 يونيو 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
06 يونيو 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces First Quarter Financial Results And Provides Corporate Update
05 مايو 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
28 أبريل 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Appointment of Three Senior Leaders
07 أبريل 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
04 أبريل 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
30 مارس 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics to Host Ovarian Cancer Program Update on Thursday, March 31, 2022
01 مارس 2022 16:05:01 بحسب Nasdaq GlobeNewswire
-
15 فبراير 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
08 فبراير 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Final Results of Previously Announced Tender Offer
20 ديسمبر 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Preliminary Results of Previously Announced Tender Offer
16 ديسمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Waiver of Condition to its Tender Offer for Common Shares
15 ديسمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Extension of Previously Announced Tender Offer
08 ديسمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
08 نوفمبر 2021 08:30:01 بحسب Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Third Quarter Financial Results And Provides Corporate Update
03 نوفمبر 2021 16:05:02 بحسب Nasdaq GlobeNewswire
-
27 أكتوبر 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
17 سبتمبر 2021 08:30:00 بحسب Nasdaq GlobeNewswire